APP and Alzheimer disease: The PDAPP model was the first AD mouse model developed, overexpressing the human APP gene with the Indiana mutation (V717F) found in the early 1990s, in which a valine is substituted by a phenylalanine at the residue 717, using the PDGF-β promoter [45,46].